Author

Masaya Shigeno

Observed names: M. Shigeno, MASAYA SHIGENO, Masaya SHIGENO, Shigeno Masaya

Institution: Japanese Red Cross Nagasaki Genbaku Hospital

Observed institutions: Japanese Red Cross Society, Japan, Nagasaki University, Japanese Red Cross Nagasaki Genbaku Hospital

ORCID: 0009-0009-8529-2033

Observed ORCID: 0009-0009-8529-2033

OpenAlex ID: A5084452918

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

2003 · Kazuyuki Ohata, Keisuke Hamasaki, et al. · Cancer · 318

PDF

Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivation

2003 · Masaya Shigeno, Kazuhiko Nakao, et al. · Oncogene · 122

Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells

2002 · Seigou Abiru, Kazuhiko Nakao, et al. · Hepatology · 111

Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group

2018 · Toshie Mashiba, Kouji Joko, et al. · PLoS ONE · 59

PDF

Response to Lenvatinib Is Associated with Optimal RelativeDose Intensity in Hepatocellular Carcinoma: Experience in Clinical Settings

2019 · Ryu Sasaki, Masanori Fukushima, et al. · Cancers · 57

PDF

The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study

2021 · Kaoru Tsuchiya, Masayuki Kurosaki, et al. · Cancers · 54

PDF

Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma

2022 · Ryu Sasaki, Kazuyoshi Nagata, et al. · Cancers · 39

PDF

Management of Pancreatolithiasis: A Nationwide Survey in Japan

2018 · Kazuo Inui, Atsushi Masamune, et al. · Pancreas · 37

Involvement of IL-1β and IL-10 in IFN-α-mediated antiviral gene induction in human hepatoma cells

2002 · Tatsuki Ichikawa, Kazuhiko Nakao, et al. · Biochemical and Biophysical Research Communications · 37

Real‐world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group

2018 · Takehiro Akahane, Masayuki Kurosaki, et al. · Hepatology Research · 33

Real‐world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group

2019 · Toshie Mashiba, Kouji Joko, et al. · Hepatology Research · 24

PDF

Geranylgeraniol, an Intermediate Product in Mevalonate Pathway, Induces Apoptotic Cell Death in Human Hepatoma Cells: Death Receptor‐independent Activation of Caspase‐8 with Down‐regulation of Bcl‐xL Expression

2001 · Yoshio Takeda, Kazuhiko Nakao, et al. · Japanese Journal of Cancer Research · 24

PDF

Acquired nephrogenic diabetes insipidus secondary to distal renal tubular acidosis and nephrocalcinosis associated with Sjögren’s syndrome

1994 · Yuji Nagayama, M. Shigeno, et al. · Journal of Endocrinological Investigation · 20

Interferon alpha inhibits the nuclear factor kappa B activation triggered by X gene product of hepatitis B virus in human hepatoma cells

2003 · Kazuyuki Ohata, Tatsuki Ichikawa, et al. · FEBS Letters · 14

Viral eradication reduces all‐cause mortality in patients with chronic hepatitis C virus infection who had received direct‐acting antiviral therapy

2024 · Toshifumi Tada, Masayuki Kurosaki, et al. · Liver International · 12

PDF

Liver Function in Older Patients With Unresectable Hepatocellular Carcinoma After Administration of Lenvatinib

2021 · RYU SASAKI, MASANORI FUKUSHIMA, et al. · Anticancer Research · 8

PDF

Management for pancreatolithiasis: a nationwide survey in Japan

2017 · Kazuo INUI, Atsushi MASAMUNE, et al. · Suizo · 7

PDF

Rectal Paraganglioma

2018 · Tomonori Araki, Shigeyuki Takeshita, et al. · Internal Medicine · 5

PDF

Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter study

2024 · Atsuhiro Morita, Nobuharu Tamaki, et al. · JGH Open · 4

Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study Group

2022 · Toshie Mashiba, Kouji Joko, et al. · Journal of Viral Hepatitis · 4

The efficacy and safety of lenvatinib in patients who did not meet the inclusion criteria of the phase 3 trial (REFLECT trial) in real-world practice in Japan: A nationwide multicenter study in Japan.

2019 · Kaoru Tsuchiya, Masayuki Kurosaki, et al. · Journal of Clinical Oncology · 4

2024 · Satoshi Miuma, Hisamitsu Miyaaki, et al. · Journal of Medical Virology · 2

PDF

Efficacy of Lenvatinib as Subsequent Therapy After Combination Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma

2026 · NAOKI UCHIHARA, NOBUHARU TAMAKI, et al. · Anticancer Research

First Reported Case of Human Infection With Helicobacter cynogastricus

2025 · Mayuko Kakizoe, Tomotaka Mori, et al. · The American Journal of Gastroenterology

The Effect of Carnitine on the Quality of Life and Sleep-Wake Disturbance in Patients With Liver Cirrhosis

2020 · Hisamitsu Miyaaki, Masafumi Haraguchi, et al.

PDF

Works count: 29

Citation count: 995

H-index: 14

I10-index: 15